TOPLINE: Patients with metabolic dysfunction-associated steatotic liver disease (MASLD) face significantly higher risks of dying from nearly all major causes, with the most pronounced relative risks observed for hepatocellular carcinoma (HCC) and liver-related deaths, and the highest absolute mortality rates for non-HCC cancer and cardiovascular disease. METHODOLOGY: MASLD is the most common chronic liver disease … Read more
As a transplant hepatologist in Los Angeles, Brian Lee, MD, MAS, has seen his share of alcoholics with advanced liver disease, people who have spent decades drinking their body toward an early death. In recent years, however, the demographic of these patients has shifted in a particularly worrisome direction. More than ever, young adults and … Read more
TOPLINE: Patients with celiac disease have a twofold higher risk for developing any chronic liver disease than the general population, with the risk remaining elevated beyond 25 years after diagnosis. METHODOLOGY: A recent meta-analysis reported that approximately one fifth of patients with celiac disease have elevated aminotransferase levels, potentially signaling underlying liver injury or risk … Read more